Computational Drug Discovery Part 5 (Subpart 1/3): Generative Models for De Novo Drug Design - VAE and GAN
From prediction to creation (Subpart 1/3): A quick intro to how AI generates novel drug molecules optimized for multiple objectives using VAE and GAN model architectures.